Omkar Speciality Chemicals Limited
Incorporated in 1993, Omkar Specialty Chemicals Ltd is engaged in the manufacture and sale of Specialty Chemicals and Pharma Intermediates for Chemical and Allied Industries.
What Omkar files
- Others9
- Board Meeting5
- Updates4
- Important3
- Dividend/Bonus2
- Results1
The company clarified exchange queries on its FY26 audited financial results, submitting a revised, more legible version with an unmodified audit opinion. The financial figures remain unchanged. These results reflect the approved resolution plan, including a ₹226.65 Cr resolution amount and significant asset/liability restatement, upholding the going concern view.
Omkar Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Omkar Speciality Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
Omkar Speciality Chemicals announced a board meeting on June 12, 2026, approving standalone audited financial results for FY26, with a net loss of ₹1.59 Cr. A Nomination & Remuneration Committee was formed, and the registered office address changed. The company is in revival mode post-Resolution Plan approval, despite suspended operations.
Omkar Specialty Chemicals' board approved backlogged financial results for FY23, FY24, and FY25. This clears the slate after its NCLT-approved resolution plan and new management took over in Jan 2026. Losses continue.